Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Vision|May 19, 2012
Androgen regulation of gene expression in human meibomian gland and conjunctival epithelial cellsPayal Khandelwal, Shaohui Liu, David A Sullivan
International Journal of Cell Biology|April 24, 2010
The N-terminal domain of y-box binding protein-1 induces cell cycle arrest in g2/m phase by binding to cyclin d1Payal Khandelwal, Mythili K Padala, John Cox, et al.
The American Journal of Pathology|April 18, 2012
Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitisSimona Schlereth, Hyun Soo Lee, Payal Khandelwal, et al.
Investigative Ophthalmology & Visual Science|March 26, 2010
Culture, immortalization, and characterization of human meibomian gland epithelial cellsShaohui Liu, Mark P Hatton, Payal Khandelwal, et al.
Plos One|October 3, 2013
Ocular allergy modulation to hi-dose antigen sensitization is a Treg-dependent processHyun Soo Lee, Simona Schlereth, Payal Khandelwal, et al.
Plos One|May 22, 2013
Ocular mucosal CD11b+ and CD103+ mouse dendritic cells under normal conditions and in allergic immune responsesPayal Khandelwal, Tomas Blanco-Mezquita, Parisa Emami, et al.
Journal of Pediatric Ophthalmology and Strabismus|January 17, 2017
Rate of Strabismus Detection on Digital Photographs Increases by Using Off-center Near TargetRon Maor, Joanna Holland, Vijay Tailor, et al.
Pilot and Feasibility Studies|December 15, 2016
Prescribed computer games in addition to occlusion versus standard occlusion treatment for childhood amblyopia: a pilot randomised controlled trialVijay K Tailor, Selina Glaze, Payal Khandelwal, et al.
Lancet (London, England)|May 4, 2024
Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trialFrank A Proudlock, Michael Hisaund, Gail Maconachie, et al.
BMJ Open|July 30, 2024
Feasibility of a new 'balanced binocular viewing' treatment for unilateral amblyopia in children aged 3-8 years (BALANCE): results of a phase 2a randomised controlled feasibility trialAnnegret Hella Dahlmann-Noor, John A Greenwood, Andrew Skilton, et al.
Pageof 2